Seelos Therapeutics Announces Acquisition of an Exclusive License to Intellectual Property from The UC Regents
Asterias Biotherapeutics Announces New Exclusive License Agreement with The Regents of the University of California
Alvopetro Announces Q3 2026 Dividend of US$0.12 Per Share and Supplementary Information on December 31, 2025 Prospective Resources
Skyharbour Partner Company Purecore Commences Data Compilation and Target Generation at The Yurchison Uranium Property